Further Information
ZMYND11, BS69, adenovirus 5 E1A binding protein, ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11, zinc finger, MYND domain containing 11, BRAM1, MGC111056, RP11-486H9.1, BS69 variant 1, BS69 variant 2, BS69 variant 3, BS69 variant 4, OTTHUMP00000018935, OTTHUMP00000018937, adenovirus 5 E1A binding protein, bone morphogenetic protein receptor-associated molecule 1
Peptide ELISA: antibody detection limit dilution 1:32000.Immunofluorescence: Strong expression of the protein seen in the nuclei of U2OS cells. Recommended concentration: 10ug/ml.
- Hateboer G, Gennissen A, Ramos YF, Kerkhoven RM, Sonntag-Buck V, Stunnenberg HG, Bernards R. BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J. 1995 Jul 3;14(13):3159-69.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog, Pig, Cow
The immunogen for this antibody is: SRVHGMHPKETT-C
10771
zinc finger, MYND-type containing 11
ZMYND11
Homo sapiens
Liquid
NP_006615.2, NP_997644.2, NP_001189393.1, NP_001189394.1, NP_001189395.1, NP_001189396.1, NP_001189397.1
5729746
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognise all reported human isoforms (NP_006615.2; NP_997644.2; NP_001189393.1; NP_001189394.1; NP_001189395.1; NP_001189396.1; NP_001189397.1).
Q15326